Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study. J. Trop. Pharm. Chem [Internet]. 2021 Dec. 31 [cited 2025 Apr. 19];5(4):347-52. Available from: https://jtpc.ff.unmul.ac.id/index.php/jtpc/article/view/257